Key facts
- This page summarizes Sandra L. Phillips's Form 4 filing for Chemours Co (CC).
- 1 reported transaction and 1 derivative row are listed below.
- Accepted by SEC: 03 Oct 2023, 19:38.
Sandra L. Phillips - 29 Sep 2023 Form 4 Insider Report for Chemours Co (CC)
- Reporting relationship
- Director
- Issuer ticker
- CC
- Reported as of
- 29 Sep 2023
- Net transaction value
- +$25,000
- SEC form
- 4
- Accepted by SEC
- 03 Oct 2023, 19:38:14 UTC
- Prior SEC filing
- 12 Sep 2023
- Next SEC filing
- 12 Dec 2023
- Source filing
- View source filing
- Reporting owner signature
- /s/ Nicole Perez Lengel, Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Sandra L. Phillips filed Form 4 for Chemours Co (CC) on 03 Oct 2023.
Change
- Previous filing in this sequence was filed on 12 Sep 2023.
- Current net transaction value: +$25,000.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
CC
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 15,934
- Date
- 29 Sep 2023
- Ownership
- Direct
- Footnotes
- F1
CC
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 378
- Date
- 29 Sep 2023
- Ownership
- By Spouse
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
CC
transaction
Derivative
Stock Units
Award
- Transaction value
- $25,000
- Shares
- +891
- Change %
- +22%
- Price
- $28.05
- Shares after
- 4,973
- Date
- 29 Sep 2023
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 891
- Exercise price
- Footnotes
- F2, F3
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 3 footnotes
Footnote F1
Includes stock units and dividend equivalent units.
Footnote F2
Units are credited under the Chemours deferred compensation plan for directors and convert one-for-one to Chemours common stock.
Footnote F3
Payable in 2028 per election under the Chemours deferred compensation plan for directors.
SEC remarks
Power of Attorney attached as Exhibit 24.